bluebird bio Ownership | Who Owns bluebird bio?


OverviewForecastRevenueFinancialsChartTranscripts

bluebird bio Ownership Summary


bluebird bio is owned by 71.82% institutional investors, 0.63% insiders, and 27.55% retail investors. Blackrock is the largest institutional shareholder, holding 14.15% of BLUE shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.02% of its assets in bluebird bio shares.

BLUE Ownership Benchmark


TypeName% Inst% Insiders% Retail
Stockbluebird bio71.82%0.63%27.55%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock15.44M14.15%$15.20M
Vanguard group10.30M9.44%$10.14M
Ameriprise financial6.39M5.86%$6.29M
Millennium management5.15M4.72%$5.07M
Palo alto investors lp4.63M4.25%$4.56M
Geode capital management4.52M4.14%$4.45M
State street3.80M3.48%$3.74M
Fmr2.30M2.10%$2.26M
Northern trust1.62M1.48%$1.59M
Aqr capital management1.33M1.22%$1.22M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Lion point capital, lp678.26K1.22%$667.54K
Palo alto investors lp4.63M0.53%$4.56M
Birchview capital, lp311.20K0.28%$306.28K
Summit x582.46K0.13%$577.50K
Orion investment225.76K0.09%$222.20K
Masters capital management975.00K0.05%$959.60K
Virtu financial277.77K0.02%$273.00K
Enterprise bank & trust30.00K0.01%$29.53K
Sargent investment group38.52K0.01%$37.91K
Allegheny financial group25.00K0.01%$24.61K

Top Buyers

HolderShares% AssetsChange
Aqr capital management1.33M0.00%1.01M
Mirae asset global etfs457.42K0.00%457.42K
Deutsche bank ag\1.17M0.00%443.24K
State street3.80M0.00%370.41K
Summit x582.46K0.13%352.69K

Top Sellers

HolderShares% AssetsChange
Granahan investment management---7.71M
Tang capital management---2.50M
Pfm health sciences, lp---2.04M
Two sigma investments, lp907.98K0.00%-1.87M
Frazier life sciences management---1.71M

New Positions

HolderShares% AssetsChangeValue
Mirae asset global etfs457.42K0.00%457.42K$450.19K
Orion investment225.76K0.09%225.76K$222.20K
Corebridge financial103.10K0.00%103.10K$101.47K
Allegheny financial group25.00K0.01%25.00K$24.61K
Vanguard personalized indexing management19.38K0.00%19.38K$19.08K

Sold Out

HolderChange
Zurcher kantonalbank (zurich cantonalbank)-3.00
Concord wealth partners-4.00
Headlands-6.00
Nelson, van denburg & campbell wealth management group-23.00
Rothschild investment-120.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2024154-7.23%78,352,735-23.87%710.81%61-29.07%4714.63%
Mar 31, 2024166-16.16%102,924,462-21.06%940.66%86-25.86%412.50%
Dec 31, 202319813.14%130,383,44745.79%1191.77%11661.11%40-14.89%
Sep 30, 2023175-5.41%89,432,819-4.40%821.00%72-23.40%4714.63%
Jun 30, 2023185-1.07%93,546,041-3.54%901.02%942.17%41-4.65%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv5.86M3.02%-
iShares Russell 2000 ETF5.01M2.58%-11.26K
ACATIS Datini Valueflex Fonds A3.30M1.70%30.43K
Vanguard Institutional Extnd Mkt Idx Tr3.19M1.65%-
Fidelity Select Pharmaceuticals Port2.23M1.15%-
Fidelity Small Cap Index1.97M1.02%-16.88K
iShares Russell 2000 Value ETF1.84M0.95%-
M&G (ACS) Granahan US Sm Cp Gr GBPZ1AAcc1.81M0.93%86.07K
iShares Biotechnology ETF1.30M0.67%-7.75K
State St Russell Sm/Mid Cp® Indx NL Cl C1.17M0.61%-

Recent Insider Transactions


DateNameRoleActivityValue
Sep 30, 2024Klima Thomas J See RemarksSell$528.85
Sep 30, 2024Obenshain Andrew President and CEOSell$18.27K
Jun 03, 2024Klima Thomas J See RemarksSell$3.73K
Mar 01, 2024Colvin Richard A Chief Medical OfficerSell$10.34K
Mar 04, 2024Obenshain Andrew President and CEOSell$9.31K

Insider Transactions Trends


DateBuySell
2024 Q4--
2024 Q3-2
2024 Q2-1
2024 Q1-8
2023 Q4-3

BLUE Ownership FAQ


Who Owns bluebird bio?

bluebird bio shareholders are primarily institutional investors at 71.82%, followed by 0.63% insiders and 27.55% retail investors. The average institutional ownership in bluebird bio's industry, Biotech Stocks , is 44.97%, which bluebird bio exceeds.

Who owns the most shares of bluebird bio?

bluebird bio’s largest shareholders are Blackrock (15.44M shares, 14.15%), Vanguard group (10.3M shares, 9.44%), and Ameriprise financial (6.39M shares, 5.86%). Together, they hold 29.46% of bluebird bio’s total shares outstanding.

Does Blackrock own bluebird bio?

Yes, BlackRock owns 14.15% of bluebird bio, totaling 15.44M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 15.2M$. In the last quarter, BlackRock increased its holdings by 263.65K shares, a 1.74% change.

Who is bluebird bio’s biggest shareholder by percentage of total assets invested?

Lion point capital, lp is bluebird bio’s biggest shareholder by percentage of total assets invested, with 1.22% of its assets in 678.26K bluebird bio shares, valued at 667.54K$.

Who is the top mutual fund holder of bluebird bio shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of bluebird bio shares, with 3.02% of its total shares outstanding invested in 5.86M bluebird bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools